Abatacept for the treatment of rheumatoid arthritis after the failure of conventional disease-modifying anti-rheumatic drugs

  • Technology appraisal guidance
  • TA234
  • Published: 

This guidance has been updated and replaced by NICE technology appraisal guidance 280.